Rivaroxaban Bayer 20 mg, Filmtabletten - 28 Swissmedic Key 69235016 CM Registration Holder Bayer (Schweiz) AG Name Rivaroxaban Bayer 20 mg, Filmtabletten Date of registration 02.03.2023 Introduction of Sequence 02.03.2023 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size 28 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680692350169 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 20 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 22.9 mg, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 3350, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 0.6 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 20 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Überzug Lactose Monohydrate 22.9 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto
Source Data was imported : 14.04.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
